Artigo de periodico

Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance (2023)

• Authors:
  • Santos, Silvia Regina Cavani Jorge
  • Camargo, Thais Vieira de
  • Messiano, Claudia Garcia
  • Kupa, Leonard de Vinci Kanda
  • Morales Júnior, Ronaldo
  • Souza, Vanessa Kasubeck de
  • Pires, Frederico Ribeiro
  • Pinto, Débora Cristina Sanches
  • Campos, Edvaldo Vieira de
  • Silva Junior, Elson Mendes da
  • Silva Junior, João Manoel da
• USP affiliated authors: SANTOS, SILVIA REGINA CAVANI JORGE - FCF ; SILVA JUNIOR, JOÃO MANOEL DA - FM ; KUPA, LEONARD DE VINCI KANDA - FM ; PINTO, DÉBORA CRISTINA SANCHES - FM ; SILVA JÚNIOR, ELSON MENDES DA - FM
• Unidades: FCF; FM
• DOI: 10.15406/ppij.2023.11.00403
• Subjects: CHOQUE SÉPTICO; QUEIMADURAS
• Language: Inglês
• Imprenta:
  • Publisher place: Oklahoma
  • Date published: 2023
• Source:
  • Título: Pharmacy and Pharmacology International Journal
  • ISSN: 2379-6367
  • Volume/Número/Paginação/Ano: v. 11,n. 2, p. 62‒68, 2023


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui acesso gratuito no site do editor (Bronze Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SANTOS, Silvia Regina Cavani Jorge et al. Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance. Pharmacy and Pharmacology International Journal, v. 11, n. 2, p. 62‒68, 2023Tradução . . Disponível em: https://dx.doi.org/10.15406/ppij.2023.11.00403. Acesso em: 16 abr. 2026.

• APA

  Santos, S. R. C. J., Camargo, T. V. de, Messiano, C. G., Kupa, L. de V. K., Morales Júnior, R., Souza, V. K. de, et al. (2023). Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance. Pharmacy and Pharmacology International Journal, 11( 2), 62‒68. doi:10.15406/ppij.2023.11.00403

• NLM

  Santos SRCJ, Camargo TV de, Messiano CG, Kupa L de VK, Morales Júnior R, Souza VK de, Pires FR, Pinto DCS, Campos EV de, Silva Junior EM da, Silva Junior JM da. Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance [Internet]. Pharmacy and Pharmacology International Journal. 2023 ; 11( 2): 62‒68.[citado 2026 abr. 16 ] Available from: https://dx.doi.org/10.15406/ppij.2023.11.00403

• Vancouver

  Santos SRCJ, Camargo TV de, Messiano CG, Kupa L de VK, Morales Júnior R, Souza VK de, Pires FR, Pinto DCS, Campos EV de, Silva Junior EM da, Silva Junior JM da. Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance [Internet]. Pharmacy and Pharmacology International Journal. 2023 ; 11( 2): 62‒68.[citado 2026 abr. 16 ] Available from: https://dx.doi.org/10.15406/ppij.2023.11.00403

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Combating bacterial resistance to antimicrobials in severe septic ICU patients: importance of meropenem, piperacillin serum monitoring as a dose adjustment and duration of infusion strategies
• Bioanalytical methods based on liquid chromatography for the therapeutic drug monitoring of combined therapies of antibiotics in pediatric septic major burns
• Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers
• Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains
• Beta-lactam agents serum measurements by liquid chromatography to evaluate meropenem and piperacillin effectiveness in septic burn adults with a pharmacokinetic-pharmacodynamic approach
• Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock
• The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus
• Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns
• Combating bacterial resistance to Meropenem by infusion strategy applied to septic burn patients with vasopressor requirements or acute kidney injury to achieve the target
• Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients